Remove Big Data Remove Engineer Remove Life Science Remove Pharma Companies
article thumbnail

What’s the next step in big data and AI?

Drug Discovery World

Big data and AI are all the rage. But, beyond these buzzwords and the quantity of data, what’s next for these powerful tools? I love innovation and working with incredible minds in the pharmaceutical and life science fields who create amazing new technologies and methods of treatment,” says Groetken.

article thumbnail

Synthetic control arms in clinical trials: Making it happen

pharmaphorum

Across the industry, pharma companies are turning to AI and real-world data to address many of the challenges of running clinical trials. Can the combined potential of new AI technologies and real-world patient data hold the key to overcoming the challenges in clinical trial design that have historically led to trial failure?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Empowering rare disease patient advocacy organisations with data

pharmaphorum

Sun says because of this, Komodo engineered solutions or apps that “do certain things for end-users applied against the Healthcare Map.”. Therefore, organisations can determine how they’d like to use the Map’s data then create a software solution that helps them do so. About the author.

article thumbnail

How digital innovation is helping therapeutics to get to market faster

Drug Discovery World

Biopharma and biotech companies without these capabilities are keen to harness these technologies and the number of strategic partnerships with such companies is accelerating at an unprecedented rate. By making lab automation as easy as using a smartphone, the Flex robot democratises access to automation in life sciences research.”